News

Gilead Sciences CEO on FDA approval of Yeztugo: A milestone moment in the history of HIV
Gilead Sciences chairman and CEO Daniel O’Day joins 'Squawk Box' to discuss the FDA approval of the company's HIV prevention ...
Gilead Sciences - Born With HIV in the 80s: Kim's Story of Growing Up as a Dandelion
NORTHAMPTON, MA / ACCESS Newswire / June 24, 2025 / Kim Canady was only nine years old in 1996 when she faced the ...
Gilead, Kymera Partner in $750M Deal to Develop Novel Molecular Glue Degraders for Cancer
Gilead Sciences Inc. (NASDAQ:GILD) is one of the undervalued S&P 500 stocks to buy according to hedge funds. On June 25, ...
Fierce Pharma2d
Uptake of Gilead's Yeztugo will be swift, analyst says after discussion with HIV doc
What kind of uptake can Gilead Sciences expect for its highly touted, long-acting HIV pre-exposure prophylaxis (PrEP) ...
Exas, Guardant, Gilead among gainers as Supreme Court ensures free preventive care
Labcorp (LH), and Gilead (GILD) rise as Supreme Court upholds right to free preventive care under Obamacare. Read more here.
Morningstar4d
Gilead Sciences - Born With HIV in the 80s: Kim's Story of Growing Up as a Dandelion - Morningstar
Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. Originally published by Gilead Sciences View additional multimedia and more ESG ...
Lenacapavir HIV shot approved in US may enter Canada by 2026; just two injections needed a year
A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...
Finanznachrichten3d
Gilead Sciences - Born With HIV in the 80s: Kim's Story of Growing Up as a Dandelion - FinanzNachrichten.de
Nachrichten » Gilead Sciences - Born With HIV in the 80s: Kim's Story of Growing Up as a Dandelion. Push Mitteilungen. ACCESS Newswire. 24.06.2025 15:26 Uhr. 4 Leser. Artikel bewerten: (0) ...
A University of Utah doctor’s research led to a major HIV drug. He worries federal cuts will stop people from getting it.
The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...
World’s only twice-a-year shot to prevent HIV could stop transmission — if people can get it
The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
KSL4d
FDA approves HIV drug based on University of Utah biochemist's findings
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...